Eslicarbazepine 50mg/1ml oral suspension sugar free
BNF presentation 0408010AIAAACAC within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0408010AIAAACAC
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
225
NHS spend (£)
£32,461.93
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 43 |
| December 2024 | 13 |
| November 2024 | 33 |
| October 2024 | 36 |
| July 2024 | 52 |
| May 2024 | 5 |
| July 2021 | 7 |
| June 2021 | 3 |
| December 2020 | 11 |
| November 2020 | 22 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
|
Beech House Surgery
ODS B82069
|
6 | 42D - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
|
Brampton Medical Practice
ODS A82012
|
5 | 01H - NORTH EAST AND NORTH CUMBRIA ICB |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |